Jump to content

Jab that will halt the most deadly forms of Cancer


Recommended Posts

Posted

Celldex Therapeutics Presents New Clinical Data from Phase 2 Study of CDX-011 in Metastatic Melanoma at 46th Annual ASCO Meeting

-Poster Presented on Study Design for Phase 2 Study of CDX-1307 in Bladder Cancer-



Mention of Pancreatic Cancer in paragraph headed ' About CDX-1307


http://www.marketwatch.com/story/celldex-therapeutics-presents-new-clinical-data-from-phase-2-study-of-cdx-011-in-metastatic-melanoma-at-46th-annual-asco-meeting-2010-06-07?reflink=MW_news_stmp


Presswatch

×
×
  • Create New...